New Pre-Treatment aims to cure sickle cell with fewer complications
NCT ID NCT05249452
Summary
This study tested whether giving two drugs (azathioprine and hydroxyurea) for three months before a stem cell transplant could help the transplant work better in adults with sickle cell disease. The goal was to help patients' bodies accept the donor cells more completely, potentially curing the disease and allowing them to stop taking anti-rejection medication sooner. The study involved 20 patients who received stem cells from a matched sibling donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam Medical Centre
Amsterdam, Netherlands
Conditions
Explore the condition pages connected to this study.